Summary
1. Properties of the muscarinic cholinergic receptor sites in the rat atrial homogenate and microsomal fraction were studied by the use of tritium labelled 3′-quinuclidinyl benzilate ([3H]-QNB), a potent muscarinic antagonist. 2. The specific [3H]-QNB binding to the receptor sites displayed saturability, stereospecificity as well as reversibility. 3. The competition studies showed that muscarinic antagonists were more potent than muscarinic agonists. 4. Certain neuromuscular blocking agents, antipsychotics, antiarrhythmics and antihistamines also were capable of interacting with the [3H]-QNB binding sites. However, α- and β-adrenergic agents, calcium antagonist (D-600) and ionophore (A-23187) failed to show any effect. 5. Analyses by the double reciprocal plot, Hill plot and Scatchard plot of the dependence of the specific [3H]-QNB binding on the concentration of QNB suggested that binding was occurring to a single population of receptor sites in the atrial homogenate or microsomal fraction. Further, there was no evidence of any detectable site to site interactions (positive or negative cooperative type). From the Scatchard plot, the equilibrium dissociation constant (KD) of 1.1 nM was calculated and the Hill coefficient was close to 1.0 6. Interaction of the muscarinic antagonists with the [3H]-QNB sites showed the Hill coefficients close to 1.0 whereas for the agonists, the coefficients were much less than 1.0 indicating that agonist-receptor site interactions have some different characteristics from those following antagonist-receptor site interaction. 7. The rate and the maximal level of QNB binding to the receptor sites was markedly influenced by the temperature; various cations, on the other hand, displayed no effect either on the association or dissociation of QNB binding. The specific QNB binding exhibited a broad pH optimum from pH 6.0–8.5. 8. Treatment of the membrane fraction (or homogenate) with either phospholipase A or C and with p-chloromercuribenzoate caused significant inhibition of [3H]-QNB binding. 9. The QNB binding site was resistant to tryptic digestion. Even when about 40% of the membrane proteins were removed by the tryptic proteolysis, the [3H]-QNB binding ability of the membrane remained unaffected; in fact, the removal of tryptic proteolytic products by centrifugation markedly increased the specific QNB binding to the membrane.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aronstam, R. S., Abood, L. G., Baumgold, J.: Role of phospholipids in muscarinic binding by neural membranes. Biochem. Pharmacol. 26, 1689–1695 (1977)
Aronstam, R. S., Abood, L. C., Hass, W.: Influence of sulfhydryl reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain. Mol. Pharmacol. 14, 575–586 (1978)
Beld, A. J., Ariëns, E. J.: Stereospecific binding as a tool in attempts to localize and isolate muscarinic receptors. Part II. Binding of (±)-benzetimide, (−)-benzetimide and atropine to a fraction from bovine tracheal smooth muscle and to bovine caudate nucleus. Eur. J. Pharmacol. 25, 203–209 (1974)
Birdsall, N. J. M., Hulme, E. C.: Biochemical studies on muscarinic acetylcholine receptors. J. Neurochem. 27, 7–16 (1976)
Birdsall, N. J. M., Burgen, A. S. V., Hulme, E. C.: The binding of agonists to brain muscarinic receptors. Mol. Pharmacol. 14, 723–736 (1978)
Brown, O. M.: Cat heart acetylcholine: Structural proof and distribution. Am. J. Physiol. 231, 781–785 (1976)
Cavey, D., Vincent, J. P., Lazdunski, M.: The muscarinic receptor of heart cell membranes: Association with agonists, antagonists and antiarrhythmic agents. FEBS Lett. 84, 110–114 (1977)
De Meyts, P.: Cooperative properties of hormone receptors in cell membranes. J. Supramol. Struct. 4, 241–258 (1976)
De Meyts, P., Roth, J., Neville, D. M., Jr., Gavin, J. R., III, Lesniak, M. A.: Insulin interactions with its receptors: Experimental evidence for negative cooperativity. Biochem. Biophys. Res. Commun. 55, 154–161 (1973)
Eldefrawi, M. E., Eldefrawi, A. T.: Characterization and partial purification of the acetylcholine receptor from Torpedo electroplax. Proc. Natl. Acad. Sci. USA 69, 1776–1780 (1972)
Fields, J. Z., Roeske, W. R., Morkin, E., Yamamura, H. I.: Cardiac muscarinic cholinergic receptors: Biochemical identification and characterization. J. Biol. Chem. 253, 3251–3258 (1978)
Fleisch, J. H., Krzan, M. C., Titus, W.: Alterations in pharmacologic receptor activity by dithiothreitol. Am. J. Physiol. 227, 1243–1248 (1974)
Galper, J. B., Smith, T. W.: Properties of muscarinic acetylcholine receptors in heart cell cultures. Proc. Natl. Acad. Sci. USA 75, 5831–5835 (1978)
Galper, J. B., Klein, W., Catterall, W. A.: Muscarinic acetylcholine receptors in developing chick heart. J. Biol. Chem. 252, 8692–8699 (1977)
Gray, J. A., Lüllmann, H., Mitchelson, F., Reil, G.-H.: Stereoselective binding in cardiac tissue of the enantiomers of benzetimide, an antimuscarinic drug. Br. J. Pharmacol 56, 485–490 (1976)
Heilbronn, E., Bartfai, T.: Muscarinic acetylcholine receptor. Prog. Neurobiol. 11, 171–188 (1978)
Higgins, C. B., Vatner, S. F., Braunwald, E.: Parasympathetic control of the heart. Pharmacol. Rev. 25, 119–155 (1973)
Hill, A. V.: The mode of action of nicotine and curare, determined by the form of the contraction curve and the method of temperature coefficients. J. Physiol. (Lond.) 39, 361–373 (1909)
Hughes, R., Chapple, D. J.: Cardiovascular and neuromuscular effects of dimethyl tubocurarine in anaesthetized cats and rhesus monkeys. Brit. J. Anaesth. 48, 847–852 (1976)
Hurko, O.: Specific [3H]quinuclidinyl benzilate binding activity in digitonin-solubilized preparations from bovine brain. Arch. Biochem. Biophys. 190, 434–445 (1978)
Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. L., Demoen, P., Lenaerts, F. M., Van Neuten, J. M., Van Wijngaarden, I., Brugmans, J. Benzetimide and its optical isomers. Arzneim. Forsch. 21, 1365–1373 (1971)
Kloog, Y., Sokolovsky, M.: Muscarinic acetylcholine receptors interactions: Competition binding studies with agonists and antagonist. Brain Res. 134, 167–172 (1977)
Lefkowitz, R. J., Limbird, L. E., Mukherjee, C., Caron, M. G.: The β-adrenergic receptor and adenylate cyclase. Biochim. Biophys. Acta 457, 1–39 (1976)
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurements with the Folin phenol reagent. J. Biol. Chem. 193, 265–275 (1951)
Lüllmann, H., Ziegler, A.: A transient state concept of drug receptor interaction. Naunyn-Schmiedeberg's Arch. Pharmacol. 280, 1–21 (1973)
Ma, S. K., Sulakhe, P. V., Leung, N. L. K.: Binding of [3H]atropine by cardiac plasma membrane-enriched fractions. In: Recent advances in studies on cardiac structure and metabolism (T. Kobayashi, T. Sano, N. S. Dhalla, eds.), 11, 249–265. Baltimore: University Park Press 1978
Moe, G. K., Abildskov, J. A.: Antiarrhythmic drugs. In: The pharmacological basis of therapeutics (L. S. Goodman, A. Gilman, eds.), 5, 683–704. New York: MacMillan 1975
Narayanan, N., Sulakhe, P. V.: 5′-Guanylylimidodiphosphate-activated adenylate cyclase of cardiac sarcolemma displays higher affinity for magnesium ions. Mol. Pharmacol. 13, 1033–1047 (1977)
Scatchard, G.: The attractions of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 51, 660–672 (1949)
Sharma, V. K., Banerjee, S. P.: Muscarinic cholinergic receptors in rat heart: Effects of thyroidectomy. J. Biol. Chem. 252, 7444–7446 (1977)
Snyder, S. H., Chang, K. J., Kuhar, M. J., Yamamura, H. I.: Biochemical identification of the mammalian muscarinic cholinergic receptor. Fed. Proc. 34, 1915–1921 (1975)
Soudijn, W., Van Wijngaarden, I., Ariëns, E. J.: Dexetimide, a useful tool in acetylcholine receptor localization. Eur. J. Pharmacol. 24, 43–48 (1973)
St. Louis, P. J., Sulakhe, P. V.: Protein analysis of cardiac sarcolemma: Effects of membrane-perturbing agents on membrane proteins and calcium transport. Biochemistry 17, 4540–4550 (1978)
Stubbins, J. F., Hudgins, P. M.: Sulfhydryl group reagents: Effect on intestinal smooth muscle. Experientia 27, 669–670 (1971)
Sulakhe, P. V., Dhalla, N. S.: Adenylate cyclase of heart sarcotubular membranes. Biochim. Biophys. Acta 293, 379–396 (1973)
Wei, J.-W., Sulakhe, P. V.: Regional and subcellular distribution of myocardial muscarinic cholinergic receptors. Eur. J. Pharmacol. 52, 235–238 (1958)
Wei, J.-W., Narayanan, N., Sulakhe, P. V.: Characterization of a β-adrenoceptor-coupled adenylate cyclase system of sarcolemma. Proc. Can. Fed. Biol. Soc. 20, 176 (abstract) (1977)
Yamamura, H. I., Snyder, S. H.: Muscarinic cholinergic binding in rat brain. Proc. Natl. Acad. Sci. USA 71, 1725–1729 (1974a)
Yamamura, H. I., Snyder, S. H.: Muscarinic cholinergic receptor binding in the longitudinal muscle of the guinea pig ileum with [3H]quinuclidinyl benzilate. Mol. Pharmacol. 10, 861–867 (1974b)
Young, J. M.: Desensitisation and agonist binding to cholinergic receptors in intestinal smooth muscle. FEBS Lett. 46, 354–356 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wei, JW., Sulakhe, P.V. Properties of the muscarinic cholinergic receptors in rat atrium. Naunyn-Schmiedeberg's Arch. Pharmacol. 309, 259–269 (1979). https://doi.org/10.1007/BF00504759
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00504759